13F-HR filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 30 holding rows worth $1,294,170,857.
- Accession
- 0001855655-23-000008
- Filer
- CIK 1855655
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 30 entries on the cover page, a total value of $1,294,170,857 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,294,170,857 with VALUE read as dollars as filed, 13F file number 028-21950. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,805,717 | $124,648,645 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 1,381,711 | $86,011,510 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,270,124 | $76,156,635 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 2,347,000 | $74,212,140 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 283,605 | $61,499,744 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 1,868,946 | $59,413,793 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 150,000 | $58,459,500 | dollars as filed | put |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,415,256 | $57,458,940 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 142,259 | $55,442,600 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 238,388 | $52,624,151 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,443,762 | $52,163,121 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,424,132 | $50,737,083 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,985,430 | $50,668,174 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,120,465 | $47,250,009 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 216,093 | $38,529,382 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 989,327 | $38,089,090 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,731,046 | $33,691,345 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 1,650,499 | $27,167,214 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,395,002 | $25,137,936 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 2,423,961 | $24,918,319 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,014,239 | $24,879,283 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 865,297 | $23,994,686 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,984,813 | $22,904,742 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 9,217,150 | $21,936,817 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 6,461,467 | $19,965,933 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 85,000 | $19,635,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 893,861 | $18,896,222 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 369,615 | $18,850,365 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 1,950,327 | $18,196,551 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,004,908 | $10,631,927 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001855655-23-000008 | this filing | 2023-08-14 | acceptance time not in the bulk data set |